Abstract
The distribution of mitral stenosis (MS) in the general population is closely associated with rheumatic fever, which is the main cause of MS. Recent data from the World Health Organization (WHO) suggest that acute rheumatic fever and, as a consequence, rheumatic disease affect about 15.6 million people throughout the world. Females are affected more frequently than males, with a ratio ranging between 2:1 and 3:1 [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group a streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.
Messika-Zeitoun D, Iung B, Brochet E, et al. Evaluation of mitral stenosis in 2008. Arch Cardiovasc Dis. 2008;101:653–63.
Sliwa K, Carrington M, Mayosi BM, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719–27.
Wood P. An appreciation of mitral stenosis. Clinical features. Br Med J. 1954;4870:1051–63.
Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation. 2005;112:3584–91.
Burge DJ, DeHoratious RJ. Acute rheumatic fever. Cardiovasc Clin. 1993;23:3–23.
Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004;165:1583–1.
Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis. 2005;14:251–6.
Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J. 1992;123:1610–32.
Spencer FC. A plea for early, open mitral commissurotomy. Am Heart J. 1978;95:668–70.
Carabello BA. Timing of surgery in mitral and aortic stenosis. Cardiol Clin. 1991;9:229–38.
Hygenholtz PG, Ryan TJ, Stein SW, et al. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–84.
Arani DT, Carleton RA. The deleterious role of tachycardia in mitral stenosis. Circulation. 1967;36:511–6.
Schofield PM. Invasive investigation of the mitral valve. In: Wells FC, Shapiro LM, editors. Mitral valve disease. Oxford: Butterworth-Heineman; 1996. p. 84.
Kennedy JW, Yarnall SR, Murray JA, et al. Quantitative angiocardiography. IV. Relationships of left atrial and ventricular pressure and volume in mitral valve disease. Circulation. 1970;41:817–24.
Choi BW, Bacharach SL, Barcour DJ, et al. Left ventricular systolic dysfunction: diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. Am J Cardiol. 1995;75:526–9.
Braunwald E, Turi ZG. Pathophysiology of mitral valve disease. In: Wells FC, Shapiro LM, editors. Mitral valve disease. Oxford: Butterworth-Heineman; 1996. p. 16.
Thompson ME, Shaver JA, Leon DF. Effect of tachycardia on atrial transport in mitral stenosis. Am Heart J. 1977;94:297–306.
Stott DK, Marpole DGF, Bristow JD, et al. The role of left atrial transport in aortic and mitral stenosis. Circulation. 1970;41:1031–41.
Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 1996;77:96–8.
American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease), Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:1–148.
Vahanian A, Baumgartner H, Bax J, et al. Task force on the Management of Valvular Heart Disease of the European Society of Cardiology ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230–68.
Braundwald E. Valvular heart disease. In: Braundwald E, editor. Heart disease. Philadelphia: W.B. Saunders; 1984. p. 1063–135.
Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assessment of mitral stenosis. Circulation. 1977;55:120–8.
Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1–23.
Messika-Zeitoun D, Brochet E, Holmin C, et al. Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J. 2007;28:72–9.
Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299–308.
Iung B, Cormier B, Ducimetiere P, et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol. 1996;27:407–14.
Rahimtoola SH, Durairaj A, Mehra A, et al. Current evaluation and management of patients with mitral stenosis. Circulation. 2002;106:1183–8.
Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. Circulation. 1996;94:2124–30.
Reid CL, McKay CR, Chandraratna PA, et al. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation. 1987;76:628–36.
Nishimura RA, Rihal СS, Tajik AJ, et al. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1994;24:152–8.
Thomas JD, Newell JB, Choong CY, et al. Physical and physiological determinants of transmitral velocity: numerical analysis. Am J Physiol. 1991;260:1718–31.
Faletra F, Pezzano A Jr, Fusco R, et al. Measurement of mitral valve area in mitral stenosis: four echocardiographic methods compared with direct measurement of anatomic orifices. J Am Coll Cardiol. 1996;28:1190–7.
Thomas JD, Weyman AE. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J Am Coll Cardiol. 1987;10:923–9.
Schwammenthai E, Vered Z, Agranat O, et al. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation. 2000;102:2378–84.
Thomas JD, Wilkins GT, Choong CY, et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation. 1988;78:980–93.
Nakatani S, Masuyama T, Kodama K, et al. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure halftime and the continuity equation methods. Circulation. 1988;77:78–85.
Messika-Zeitoun D, Fung Yiu S, Cormier B, et al. Sequential assessment of mitral valve area during diastole using colour M-mode flow convergence analysis: new insights into mitral stenosis physiology. Eur Heart J. 2003;24:1244–53.
Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750–6.
de Agustin JA, Nanda NC, Gill EA, et al. The use of three-dimensional echocardiography for the evaluation of and treatment of mitral stenosis. Cardiol Clin. 2007;25:311–8.
Pérez de Isla L, Casanova С, Almerìa С, et al. Which method should be the reference method to evaluate the severity of rheumatic mitral stenosis? Gorlin’s method versus 3D-echo. Eur J Echocardiogr. 2007;8:470–3.
Applebaum RM, Kasliwal RR, Kanojia A, et al. Utility of three-dimensional echocardiography during balloon mitral valvuloplasty. J Am Coll Cardiol. 1998;32:1405–9.
Anwar AM, Attia WM, Nosir YF, et al. Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2010;23:13–22.
Soliman OI, Anwar AM, Metawei AK, et al. New scores for the assessment of mitral stenosis using real-time three-dimensional echocardiography. Curr Cardiovasc Imaging Rep. 2011;4:370–7.
Braunwald E, Moscovitz HL, Mram SS, et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular and aortic pressures; particular reference to mitral stenosis. Circulation. 1955;12:69–81.
Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J. 1951;41:1–29.
Hugenholtz PG, Ryan TJ, Stein SW, et al. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–84.
Rowe JC, Bland EF, Sprague HB, et al. The course of mitral stenosis without surgery: ten and twenty-year perspectives. Ann Intern Med. 1960;52:741–9.
Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J. 1962;24:349–57.
Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45:878–90.
Munoz S, Gallardo J, Diaz-Gorrin JR, et al. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease. Am J Cardiol. 1975;35:234–42.
Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J. 1975;37:74–8.
Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:523–661.
Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation. 1989;79:863–71.
Tamai J, Nagata S, Akaike M, et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral commissurotomy: noninvasive evaluation using continuous wave Doppler technique. Circulation. 1990;81:46–51.
Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol. 1991;17:1520–6.
Cheriex EC, Pieters FA, Janssen JH, et al. Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol. 1994;45:219–26.
Tamburino C, Russo G, Di Paola G, et al. La valvuloplastica percutanea nella stenosi mitralica. Cardiologia. 1993;38:7–17.
Palacios IF. Farewell to surgical mitral commissurotomy for many patients. Circulation. 1998;97:223–6.
Davidson MJ, Baim DS. Percutaneous catheter-based mitral valve repair. In: Cohn LH, editor. Cardiac surgery in the adult. New York: McGraw-Hill; 2008. p. 1101–8.
Marsocci G, Neri M, Natale N. Cardiopatie valvolari. II Pensiero Scientifico Editore. 2004. p. 73–103.
Fatkin D, Roy P, Morgan JJ, et al. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol. 1993;21:390–7.
Inoue K. Percutaneous transvenous mitral commissurotomy using the Inoue balloon. Eur Heart J. 1991;12:99–108.
Vahanian A, Acar J. Mitral valvuloplasty: the French experience. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders; 1994. p. 1206–25.
Block PC, Palacios IF. Aortic and mitral balloon valvuloplasty: the United States experience. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders; 1994. p. 1189–205.
Inoue K, Hungs JS. Percutaneous transvenous mitral commissurotomy (PTMC): the Far East experience. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders; 1994. p. 1226–42.
Tamburino C, Russo G, Calvi V, et al. La valvuloplastica mitralica: risultati immediati e followup a 2 anni. Cardiologia. 1993;38:367–75.
Ross J Jr. Catheterization of the left heart through the interatrial septum: a new technique and its experimental evaluation. Surg Forum. 1959;9:297–301.
Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394–402.
Iung B, Garbarz E, Michaud P, et al. Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: late efficacy and implications for patient selection. J Am Coll Cardiol. 2000;35:1295–302.
Lip G, Wasfi M, Hamil M, et al. Percutaneous balloon valvuloplasty of stenosed mitral bioprosthesis. Int J Cardiol. 1997;59:97–100.
Lin PJ, Chang JP, Chang CH. Balloon valvuloplasty is contraindicated in stenotic mitral bioprosthesis. Am Heart J. 1994;127:724–6.
Gupta A, Lokhandwala YY, Satoskar PR, et al. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. J Am Coll Surg. 1998;187:409–15.
Fawzy ME, Kinsara AJ, Stefadouros M, et al. Long-term outcome of mitral balloon valvotomy in pregnant women. J Heart Valve Dis. 2001;10:153–7.
Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893–9.
de Souza JA, Martinez EE Jr, Ambrose JA, et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol. 2001;37:900–3.
Cohen DJ, Kuntz RE, Gordon SP, et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med. 1992;327:1329–35.
Kamalesh M, Burger AJ, Shubrooks SJ. The use of transesophageal echocardiography to avoid left atrial thrombus during percutaneous mitral valvuloplasty. Cathet Cardiovasc Diagn. 1993;28:320–2.
Tsai LM, Hung JS, Chen JH, et al. Resolution of left atrial appendage thrombus in mitral stenosis after warfarin therapy. Am Heart J. 1991;121:1232–4.
Grossman W, Baim DS. Grossman’s cardiac catheterization, angiography and intervention. 7th ed. Baltimore: Lippincott Williams and Wilkins; 2006.
Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation. 2004;109:1572–9.
Dean LS, Mickel M, Bonan R, et al. Four-years follow up of patients undergoing percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J Am Coll Cardiol. 1996;28:1452–7.
Palacios IF, Tuzuc ME, Weyman AE, et al. Clinical Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation. 1995;91:671–6.
Pan M, Medina A, Lezo JJ, et al. Factors determining late success after mitral balloon valvulotomy. Am J Cardiol. 1993;71:1181–6.
Arora R, Kalra GS, Murty GS, et al. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol. 1994;23:1327–32.
Palacios IF, Block PC, Wilkins GT, Weyman AE. Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation. 1989;79:573–9.
Thomas MR, Monaghan MJ, Michalis LK, et al. Echocardiographic restenosis after successful balloon dilatation of the mitral valve with the Inoue balloon: experience of a United Kingdom centre. Br Heart J. 1993;69:418–23.
Iung B, Garbarz E, Michaud P, et al. Immediate and midterm results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J. 2000;21:1683–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Capodanno, D., Barbanti, M., Tamburino, C. (2018). Mitral Stenosis. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-59620-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59619-8
Online ISBN: 978-3-319-59620-4
eBook Packages: MedicineMedicine (R0)